Aptus Capital Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$706K	Sell	75,223 -13,859	-16%	-$130K	0.01%	596
2025 Q1	$633K	Sell	89,082 -50,196	-36%	-$357K	0.01%	581
2024 Q4	$1.62M	Buy	+139,278	New	+$1.62M	0.02%	420